Delta4 Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $4.27M

  • Investors
  • 2

Delta4 General Information

Description

Developer of an artificial intelligence-supported digital drug development platform designed to advance drug research. The company's proprietary platform integrates systems biology, computational modeling, artificial intelligence, and large-scale data, enabling pharmaceutical and biotechnology companies to understand disease mechanisms and accelerate drug development with greater precision.

Contact Information

Website
delta4.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Alser Straße 23
  • DG / Top 30
  • Vienna, Vienna 1080
  • Austria
+43 0681
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Discovery Tools (Healthcare)
Corporate Office
  • Alser Straße 23
  • DG / Top 30
  • Vienna, Vienna 1080
  • Austria
+43 0681

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Delta4 Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 07-Apr-2021 $4.27M Completed Generating Revenue
2. Accelerator/Incubator Completed Startup
1. Angel (individual) Completed Startup
To view Delta4’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Delta4 Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an artificial intelligence-supported digital drug development platform designed to advance drug research. T
Drug Discovery
Vienna, Austria
11 As of 2024

Cambridge, United Kingdom
 

Potsdam, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Delta4 Competitors (4)

One of Delta4’s 4 competitors is Healx, a Venture Capital-Backed company based in Cambridge, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Healx Venture Capital-Backed Cambridge, United Kingdom
Biotx.ai Venture Capital-Backed Potsdam, Germany
SOM Biotech Venture Capital-Backed Barcelona, Spain
Pharnext Formerly VC-backed Paris, France
To view Delta4’s complete competitors history, request access »

Delta4 Patents

Delta4 Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4686474-A1 Dpp-iv inhibitors for the treatment or prevention of autoimmune liver diseases Pending 31-Jul-2024
WO-2024017844-A1 Novel use of glucagon-like peptide 1 (glp-1) agonist Inactive 18-Jul-2022
AU-2021393786-A1 Clopidogrel for use in the treatment of focal segmental glomerulosclerosis (fsgs) Inactive 03-Dec-2020
AU-2021393786-A9 Clopidogrel for use in the treatment of focal segmental glomerulosclerosis (fsgs) Inactive 03-Dec-2020
CA-3204074-A1 Clopidogrel for use in the treatment of focal segmental glomerulosclerosis (fsgs) Pending 03-Dec-2020 A61K45/06
To view Delta4’s complete patent history, request access »

Delta4 Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Delta4 Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
EU-India Innocenter Accelerator/Incubator
Angel (individual) Minority
To view Delta4’s complete investors history, request access »

Delta4 FAQs

  • When was Delta4 founded?

    Delta4 was founded in 2019.

  • Where is Delta4 headquartered?

    Delta4 is headquartered in Vienna, Austria.

  • What is the size of Delta4?

    Delta4 has 11 total employees.

  • What industry is Delta4 in?

    Delta4’s primary industry is Drug Discovery.

  • Is Delta4 a private or public company?

    Delta4 is a Private company.

  • What is the current valuation of Delta4?

    The current valuation of Delta4 is .

  • What is Delta4’s current revenue?

    The current revenue for Delta4 is .

  • How much funding has Delta4 raised over time?

    Delta4 has raised $4.27M.

  • Who are Delta4’s investors?

    EU-India Innocenter and have invested in Delta4.

  • Who are Delta4’s competitors?

    Healx, Biotx.ai, SOM Biotech, and Pharnext are competitors of Delta4.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process